期刊
VIRULENCE
卷 12, 期 1, 页码 444-469出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/21505594.2021.1871823
关键词
Enveloped single-stranded RNA Viruses; virus-host interplay; RNases; innate Immunity; antiviral drugs
资金
- Fundacio La Marato de TV3 [20180310]
- Ministerio de Ciencia e Innovacion, Spain [PID2019-106123GB-I00]
Host RNases can combat viruses through a multifaceted strategy, including enzymatic targeting of the viral genome, recognition of unique virus patterns, immune modulation, control of stress granule formation, and induction of autophagy/apoptosis pathways.
Owing to the recent outbreak of Coronavirus Disease of 2019 (COVID-19), it is urgent to develop effective and safe drugs to treat the present pandemic and prevent other viral infections that might come in the future. Proteins from our own innate immune system can serve as ideal sources of novel drug candidates thanks to their safety and immune regulation versatility. Some host defense RNases equipped with antiviral activity have been reported over time. Here, we try to summarize the currently available information on human RNases that can target viral pathogens, with special focus on enveloped single-stranded RNA (ssRNA) viruses. Overall, host RNases can fight viruses by a combined multifaceted strategy, including the enzymatic target of the viral genome, recognition of virus unique patterns, immune modulation, control of stress granule formation, and induction of autophagy/apoptosis pathways. The review also includes a detailed description of representative enveloped ssRNA viruses and their strategies to interact with the host and evade immune recognition. For comparative purposes, we also provide an exhaustive revision of the currently approved or experimental antiviral drugs. Finally, we sum up the current perspectives of drug development to achieve successful eradication of viral infections.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据